Equipment for state-of-the-art cataract biometry

Equipment for state-of-the-art cataract biometry

New IOLMaster 700

ZEISS, the leading company in OCT (Optical Coherence Tomography) inclusion in Ophthalmology, has designed the first optical biometer. OCT SWEPT Source technology has been integrated in biometry in order to create the first SWEPT Source Biometry equipment.

Advantages of the new biometry: 

  • Increased refractive results

It is an OCT based biometry which allows to visually test measurements in order to detect unusual eye geometries.


Iol Master 700 ICR

  • Work optimization

Integrated toric IOL (intraocular lenses) dioptres power calculation, easy to delegate, high speed in measurements, toric IOL implantation with no markers.



What can ZEISS state-of-the-art biometry do?

  • Detection of unusual eye geometry, such as crystalline lens tilt or off-centre.
  • Detection of non-appropriate eye fixation detection, as it allows a clear view to the fovea and improves refractive measurements.
  • Visual checking of measurement. This new biometry allows to visually check the measured eye structure.
  • It allows for an optimal reproducibility to obtain good refractive results thanks to the exclusive SWEPT Source Biometry with 2,000 images per second.
  • Exclusive telecentric keratometry. The smart optical configuration allows for solid and reproducible measurement realization, in particular with anxious patients, which enables to obtain optimal keratometry measurements.


Post your comment

In accordance with the provisions of the General Data Protection Regulation (REGULATION (EU) 2016/679), the following information about the processing of personal data is disclosed to you.

Responsible: Institut Català de la Retina, S.L., Institut Català de Cirurgia refractiva, S.L. (from now on ICR)

Representative of Data Protection Contact: C/Pau Alcover nº 67 08017 Barcelona –

Aim: The purpose of the treatment is to manage the information you provide us and after having your consent, publish the testimonial on our website.

Legitimization: The legal basis for the present treatment is the request made by you and having your consent.

Recipients: The recipients of the information are the departments and delegations in which ICR is organized, in part or in its entirety. It will not be communicated to third parties.

Rights: At any time, you can exercise your rights of access, rectification, deletion, opposition, limitation of treatment and / or portability of data by writing to the RPD Representative of Data Protection at the address provided in contact. You can also revoke consents to other treatments. You can also request more information from the RPD about the treatments performed.
In the event that you consider that your rights have been violated, you can submit a claim to the competent Data Protection Control Authority.

For all purposes, the user accepts that the opinion expressed will be exclusively his /her responsibility. The user assumes under his / her exclusive responsibility the damages or harms that may derive from it.
ICR will not be responsible for the accuracy, quality, reliability, correctness, morality and legality of the data, information or opinions published by users.
ICR reserves the right not to publish all opinions of users.
The user is solely responsible of his /her username. ICR will not be responsible for the illegal use or for illicit purposes that other users can make of this user name.

Preservation: The collected data will be kept during the time required for the requested management, for at most 30 days.

ICR Ganduxer Headquarters

08022 Barcelona

ICR Pau Alcover

C. Pau Alcover 67
08017 Barcelona

ICR Terrassa

C. del Nord, 77
08221 Terrassa

Clínica Bonanova Surgical Center

Passeig Bonanova, 22
08022 Barcelona

Clinica Bonanova Tests and Treatments

c/ Mandri, 63
08022 Barcelona

ICR Service at Clínica Ntra. Sra. del Remei

c/ de l'Escorial,148
08024 Barcelona
This website uses cookies in order to collect statistical information regarding navigation. If you keep on surfing this website, it shall be deemed to have acknowledged its use. More information.